Spark licenses blindness gene therapy rights outside US to Novartis Medical Dialogues Bureau26 Jan 2018 9:45 AM ISTSpark Therapeutics Inc, whose breakthrough gene therapy to treat a rare form of blindness was approved by U.S. regulators in December, said on...
Philip Morris sees six million US smokers switching to iQOS device if cleared Medical Dialogues Bureau26 Jan 2018 9:30 AM ISTPhilip Morris International Inc told a U.S. advisory panel on Wednesday that it expects around 6 million smokers to switch completely to its iQOS...
Pfizer Q3 net profit up 40 percent at Rs 87 crore Medical Dialogues Bureau25 Jan 2018 11:00 AM ISTNew Delhi: Drug firm Pfizer reported a 39.87 percent rise in its net profit at Rs 87.24 crore for the quarter ended December 2017, mainly on account...
ICICI Lombard launches solution to transform OPD health Insurance Medical Dialogues Bureau25 Jan 2018 10:00 AM ISTNew Delhi: ICICI Lombard General Insurance, one of the leading general insurance companies in the country has launched a health insurance app — ‘IL...
Johnson and Johnson takes 13.6 billion dollars charge related to new US tax law Ruby Khatun Khatun25 Jan 2018 9:45 AM ISTHealthcare conglomerate Johnson and Johnson on Tuesday took a $13.6-billion charge related to the new U.S. tax law and plans to bring back billions of...
Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug Ruby Khatun Khatun25 Jan 2018 9:30 AM ISTPuma Biotechnology Inc said a European regulatory panel indicated it was unlikely to provide a positive opinion on the company’s breast cancer drug,...
Celgene to buy Juno for 9 billion dollar to boost cancer pipeline Ruby Khatun Khatun25 Jan 2018 9:30 AM ISTCelgene Corp will pay $9 billion in cash to buy experimental cancer drugmaker Juno Therapeutics Inc, bulking up its developmental pipeline as it works...
Omron Healthcare India eyes 45 percent revenue growth in FY 18-19 Ruby Khatun Khatun24 Jan 2018 10:36 AM ISTNew Delhi: Japanese medical devices maker Omron Healthcare is targeting around 45 percent rise in revenues at Rs 189 crore in the next fiscal year...
Biotech mergers and acquisitions takes off as Sanofi and Celgene spend 20 billion dollars Ruby Khatun Khatun24 Jan 2018 10:17 AM ISTBiotech deal activity exploded on Monday with French drugmaker Sanofi and U.S.-based Celgene spending a combined total of more than $20 billion to add...
FDA's tobacco stance faces test with Philip Morris iQOS device Ruby Khatun Khatun24 Jan 2018 10:05 AM ISTWASHINGTON: In a decision expected to test the Trump administration’s approach to tobacco regulation, U.S. health advisers will vote this week on...
Teva's asthma treatment fails late-stage studies Ruby Khatun Khatun24 Jan 2018 9:47 AM ISTTeva Pharmaceutical Industries said two late-stage studies testing its treatment for asthma did not meet their main goals.The studies were testing...
Morepen Labs reports 107 percent increase in Q3, net profit at Rs 9.67 crores Ruby Khatun Khatun23 Jan 2018 10:30 AM ISTNew Delhi: Morepen Laboratories Ltd has reported yet another growth-filled quarter by registering 107 percent rise in its net profit in Q3 of FY...
